Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
To evaluate the efficacy and safety of pamrevlumab versus placebo in combination with systemic corticosteroids in participants with non-ambulatory Duchenne muscular dystrophy (age 12 years and older).
Epistemonikos ID: 17997871bce048207ababa5ab0cadc5569248551
First added on: May 07, 2024